Summary:
Study evaluating the safety and therapeutic value of an investigational medicine on managing chronic back pain.
Qualified Participants Must:
• require daily back pain medication for greater than 3 months
• not be taking any medication CNS (barbituates, anxiolytic, antidepressants, antipsychotics, anti-epileptic, SSRI's, MAO's) calcuim channel blockers, H1, H2, PPI therapy, beta blockers, and cholesterol lowering statins. Herbals should not be taken.